Overview
No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.
Key stats
Aug 21- 52-wk high
- $27.98
- 52-wk low
- $17.11
- Prev close
- $23.29
- Mkt cap
- $11.77B
- Fwd P/E
- 22.3x
- Beta
- 1.69
Smart money
Earnings
Earnings came in 25.9% above what analysts expected.
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.14B | $1.14B | $1.37B | $1.37B |
| Cost of what it sold | $530.0M | $694.0M | $586.0M | $570.0M |
| Gross profit | $607.0M | $450.0M | $785.0M | $798.0M |
| What it spent | ||||
| Research and development | $89.0M | $93.0M | $97.0M | $92.0M |
| Sales and admin | $351.0M | $338.0M | $381.0M | $449.0M |
| Other operating costs | $140.0M | — | — | $148.0M |
| Total operating expenses | $580.0M | $431.0M | $478.0M | $689.0M |
| What was left | ||||
| Operating profit | $27.0M | $19.0M | $307.0M | $109.0M |
| Interest on debt | $52.0M | $91.0M | $57.0M | $59.0M |
| Profit before tax | -$50.0M | -$259.0M | $87.0M | $56.0M |
| Tax | -$16.0M | $17.0M | $30.0M | $2.0M |
| Net profit | -$34.0M | -$276.0M | $57.0M | $54.0M |
| EBITDA | $178.0M | $6.0M | $316.0M | $274.0M |
Technicals
Price structure
Technicals sync when verified market data is available. No sample data is shown.
News
What the news says
Coverage is bullish
Tone of tracked coverage
Elanco Investors Fail to Revive Sales Misrepresentation Suit
BearishAug 14Elanco Animal Health (ELAN) director purchases 5,000 shares of stock
BullishAug 13Elanco Animal Health expands US screwworm response
Leans bullishAug 12